RYAH — Groupe Ryah Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
Annual income statement for Groupe Ryah, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS |
| Status: | fx Final | Final | Final |
| Revenue | |||
| Total Revenue | 0 | 0.043 | 0.168 |
| Cost of Revenue | |||
| Gross Profit | — | 0.014 | 0.124 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | — | 2.53 | 4.65 |
| Operating Profit | 0 | -2.49 | -4.48 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | — | -2.49 | -16.2 |
| Net Income After Taxes | — | -2.49 | -16.2 |
| Net Income Before Extraordinary Items | |||
| Net Income | — | -2.49 | -16.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | — | -2.49 | -16.2 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | — | -0.005 | -0.046 |